Danish Study Finds Multiple Myeloma Tied to Highest 1-Year Heart Attack Risk Among Cancer Subtypes

A Danish study of 660,531 patients found multiple myeloma carries the highest one-year heart attack risk among cancers at 0.91%, though absolute risk remains below 1% for all types.

Patients diagnosed with multiple myeloma face a significantly higher risk of experiencing a heart attack within their first year of cancer treatment compared to other malignancies, a nationwide Danish study of 660,531 individuals has found.

Researchers analyzing registry data from 2000 to 2023 identified that individuals with multiple myeloma had a relative risk of myocardial infarction (MI) 1.80 times that of a reference group comprised of patients with low-risk skin tumors.

The study, published in the International Journal of Cardiology, examined 13 different cancer subtypes. Elevated relative risks were also identified in other categories: bladder cancer at 1.52, kidney cancer at 1.51, leukemia at 1.45, and gastrointestinal cancer at 1.37. Despite these variations in relative risk, the standardized one-year absolute MI risk remained below 1% for all cancer types, ranging from 0.31% for breast cancer to 0.91% for multiple myeloma.

The researchers said that one-year all-cause mortality rates varied significantly among the groups, ranging from 2.2% for those with low-risk skin tumors to 71.9% for patients with hepatobiliary and pancreatic cancer.

Because of these high mortality rates, the authors emphasized that competing risks must be considered when evaluating cardiovascular outcomes. A lower incidence of heart attacks in certain groups does not necessarily mean lower cardiovascular susceptibility when the mortality risk from the cancer itself is high.

The International Journal of Cardiology serves as a broad international forum for translational, clinical, and epidemiological research across all areas of cardiovascular medicine and science. Affiliated with the International Society for Adult Congenital Cardiac Disease, the publication is indexed in major databases including MEDLINE, Science Citation Index, and Scopus to support the study and management of cardiac diseases.

By publishing peer-reviewed research that informs clinical decision-making and evaluates therapeutic approaches, the journal provides a platform for integrating experimental, clinical, and population-based data to advance the understanding of cardiovascular health, disease prevention, and patient outcomes.

The findings are considered hypothesis-generating, as the observational study lacked detailed information regarding specific cancer treatment regimens, timing, and certain lifestyle-related cardiovascular risk factors. The researchers concluded that the results do not establish that the cancer subtype itself causes the differences in heart attack risk, but rather underscore the necessity for clinicians to interpret cardiovascular outcomes within the broader context of cancer prognosis and competing mortality.

Photo of author

Health Desk

Health Desk at Archyde.

Collaborazione Pastorale Noventa Fossalta Reflects on Matthew 25 Final Judgment